Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL. Different rules eh? Which drugs currently in use in the USA were originally tested and approved in Africa first, and then accepted in the USA?
The best thing for an ENZC bull is to not look into that! (we don't do that kind of research here, we are busy dreaming of buyouts instead)
Oops! Will the first line here be your answer too?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170655345
Mutat - You are 100% correct about that. However, we are still severely undervalued at the present. I'm not saying that we should be trading at $5 or anything, but a fair/accurate, yet ultra-conservative valuation for right now is around .25-.35 ($708 - $990M MC)... The .04 that we're currently trading at is laughable at best.
That's all I needed. Proof! THIS is why ENZC investors are sitting in a stock down 95% and dreaming of big pharma buying them out! Why do research? Why look at the history if it would tell a reasonable EXPERIENCED person that this drug will never succeed? Exactly!
Yeah your right, this a 30-40 yr scam in the making Pumper Stumper that you have so brilliantly uncovered in 2020, all because they never had the funding to go to clinic trials back the with Clone 3, which is widely known and public knowledge to everyone. Tell us something we don't know if you want to try to act cute/smart.
Hmmm they are...working in Africa..diff..rules..approx..70%..cases..there
DD is impt to keep up ..with
Europe is watching close as said..many times
Hmm
Puzzled why this would not be enough
What does it matter and why would I need to answer that question? I know the history behind Bioclonetics, and if you are referring to this being around for decades, that means absolutely nothing to me at the present time.
Do you deny that the NIH & Dr Fauci trying to patent the same antibody that Dr Cotropia already patented in 1989? Where as Dr Fauci admitted it had "utility" & "commercial value"? But somehow miraculously they lose in court, and the NIH snubbs them for any funding? Clone 3 was shown to be 2.6x more effective than their antibody done by Los Alamitos.
Thanks, and agreed Africa will be a huge door opener for ITV-1.
Invest in scams much? Show us for any 3 FDA approved drugs this year, that years after they developed they were in "invitro testing".
There will be no answer! Just excuses, correct?
Yes, that would be a good start! It would bring smiles to many faces!
Invest in bio-tech much? This is the way it works…
Correct. I haven't been able to find much research on this, but obviously I'm trusting ENZC & Co to be correct when it comes to selling or making ITV-1 available in several countries in Africa with just toxicology testing. Which is massive news imo when that gets completed, which should be anytime now. Basically just as good as getting a drug approval in Europe or the US, same equivalent. Africa is where you want to be anyways with ITV-1, since it has the most number of people affected by it.
Could add.. .J and J , Lilly to the list of..possible talks..
Being not ..under a pressure to put up messages am just watching to see sellers that will help another steal before CEO says something new expectations being in Dec.
Shouldn't investor that have done full due diligence look into the history to fully understand what's going on? "Initially tested several years ago at least" is hardly complete, nor informative.
See if you can find when this was first developed! Its just ENZC basic due diligence that all investors should know! What's the answer?
So, that's Clone 3 you're referring to as opposed to the final tests that ITV-1 is going through for use in Africa?
That would be nice, but our version now would be $5
I don't have the exact date as I know it was initially tested in Belgium several years ago at least. This is what Samsung Biologics has produced for us now, the recombinant form of Clone 3, and is currently being tested. Next step is funding the animal trials.....
This was from Charles back in 2019 and the Bioclonetics days......
"We are actively, very actively pursuing a pharma partner who does not require the completion of animal trails before partnering in our technological development."
"We firmly believe that our recombinant testing and then animal trials of our antibodies will produce the necessary evidence for a pharma partner to fully embrace them."
Yes, and a perfect example before our eyes with RXDX.
How long has it been since this drug was first developed, which are we in "invitro testing"? The answer should lend a clue as to why that's ridiculous!
Most people invested in ENZC do KNOW what happens after 2 years with missed dates, and eternal testing of a 10 year old drug going nowhere..... you get a stock down 95%, AS IT SHOULD BE!
Dreaming of ENZC success doesn't make it happen. All the signs are there, no one will have any excuses to blame the company or anyone else. If you invest in a POS, and reject reality of the ENZCs failures, you cannot be rewarded!
They are currently doing efficacy testing in Europe now in vitro, and this is the information I'm sure they are sharing with potential partners, ie Regeneron & Eli Lilly.
Not just that Mutat, but in the case of ENZC, if/when they get an equity partner to go to animal trials for Clone 3, it will absolutely explode from these levels no doubt. Then of course it will retrace again and so on as we get through the clinical phases.
Most people don’t realize what happens to SP when these bios completes a phase in the trials. This is where we begin to realize value and the new investors move in to push us forward. It want be long now before we experience it first hand. Look to Europe.
Ok, what ticker?
They don't do what they say when they say... furthermore, they don't do what they say AT ALL. Just payroll, by my estimates, is at least $150K per quarter and they have how much cash left? Forget leased space XP and other operating expenses. They'll have to dilute IMO, and the cap table is already blown out. Crunch time with nothing to show.
Here is an example of what could happen with ENZC.
Interesting to see what a positive phase 2 result can do for a drug development company. On 12/7/22 they announced positive results for a treatment for ulcerated colitis and will move to a phase 3 study. The stock moved from a price of $36 to today's price of $114. And just announced RXD**X is offering 4.5 million shares at $110 so they can move into the phase 3 study. This offering closes on 12/13/22.
They .. need sellers .. today to make..the..steal
Why not keep it real???? These fools simply can not do what they say when they say. Soooooonnnnnnnn ehh? Days to weeks....... Ipf in box stores in March...... Next support is just north of a penny and the real support is where the pumpers that are getting scared bought in at .006
Coicendently that is two pump and dumps away based off taking out every low by 65% pattern that's been goin on. Rember MACRO lol
Well said Dyno89! Keeping the faith here!
Not at all. Just Saying that I believe he knows who is in control and why, not that he is necessarily responsible. I guess he could be responsible if we find out that PUMA has actually been buying back shares for the co. (I’m not saying this is happening)
So what you are saying is that a company can get a MM to control your stock for a reason?
There's our sign/indicator that they're not gonna let it move today... INTL moving from their ask from their normal perch at 0.63 to .042. They don't actually want to sell a single share, they're just doing their part to hold it/deter... Completely normal though, right? I mean people buy shares all the time at > .09/.10 and then throw them on the ask for less than half of that, don't they? LOL...
Oh well, I guess it really doesn't matter what INTL does anyway, seeing as PUMA is still playing their game? If today plays out as expected, we'll be looking at next Wednesday as the earliest anything significant could drop. I still don't think the muzzle comes off until 2023, but next Wednesday-Friday would still be in the realm of possibility. Unlikely, but possible.
Thanks, TK. Hopefully they have updated these tests against what's the market now.
Although I'm sure others will disagree, Yes. I 100% absolutely believe that he knows who is in control and why... 19-20 months of some of the most obvious, coordinated, & aggressive manipulation, yet it has gone completely unchecked/unaddressed by Charles/ENZC. There has to be a reason for this.
You are making this too easy!
Audit Issues........
Originally ENZC put out a pr stating they were looking to hire a PCAOB auditor and eventually up list to the OTCQB back in Jan 2021. They hired Malone & Bailey in Feb 2021. So far so good. In June, ENZC was informed that instead of being a business combination, that it should have been a merger between them and Bioclonetics. Well, obviously a huge deal and with probably enormous consequences as far as tax purposes and such, ENZC was then required to also audit Bioclonetics for 2019 & 2020.
ENZC then contends that it should have always been a business combination, and hires a outside account consultant with specialties in this matter, Steve Heumann. The 3 sides apparently work things out, ENZC is transparent with all the information requested of them that the auditors and Steve need, so then it seemed just a matter of time. Hence the reason Dr C made the comment he thought it could be days to weeks when we see the audit, and that was early 2022. Months go by and nothing is happening, all the while Charles contends in his quarterly reports that there is no problems or further questions.
Now it's mid summer, and we find out that ENZC has let go of M&B and brought on a new auditor from Greis & Associates, Blaze Greis. The million dollar question is why? Why the switch after almost a year and half with M&B, and so much time and effort put into them getting this audit done? This is where you have to speculate, but my guess would be they simply were taking too long and just couldn't get it done for whatever reason. Do you wait longer if you are ENZC and stick with M&B to see it through? Or do you simply cut ties and hire someone else who you feel can get the job done in a timely manner? They ended up choosing the later.
So, moral of the story is ENZC was in a lose-lose situation at the time they let go M&B, knowing either way it would take a lot more time to get the audit done either way it went. Optically it looked bad, and investor confidence was lost.
But under no scenario do I believe this was a scam or Dr C was leading investors when he said days/weeks. This audit getting done is obviously huge to ENZC, definitely not required and voluntary on their part, but important enough that only a month after the business combination they were already thinking to get audited fins. When will the ever seemingly elusive audited fins come out? No definitive answer, but as long as Blaze has everything he needs from the co, and there are no remaining issues if any to be resolved, we should see them here fairly soon.
I also believe confidence can and will be restored here with ENZC, once they start selling IPF and audited fins are reported.
Forward looking statements are just that, and I think they always intend to paint the best case scenario if everything went perfectly. But I also believe the intent and determination is there to achieve all the milestones they have set out, just not in the exact timeframe that they have given. I think they have been more mindful of this overall, except for the latest one where they said IPF would be available in November.
Dyno. You make a great and indisputable NO DILUTION point. Scams always dilute to take your money. R/S indefinitely
Dyno appreciate reading. .good post/ with this..having significant and basic infm .. not only that but is more of an explanation on what the basis of certain claims are and what actually does get a lot of attention by intelligent investors and buyers of a company stock.. vs claims that need a certain amount of pertinenance to important issues.
And here is a little snippet from the article written about Clone 3 back in 2013......
Then, in August 2010, came another
landmark for Clone 3. The U.S. government’s
Los Alamos HIV Clinical Database published
a review of Clone 3 antibody’s capacity to bind
directly with the 2,229 (then) known strains
of HIV around the world. By searching the
surface (amino acid) composition of these
2,229 HIV isolates, Los Alamos found that
ninety-eight percent of them have an exact
match—or conservative amino-acid substitu-
tion—for the minimal essential “core” epitope
KLIC to which the CLONE 3 antibody binds.
In other words, Clone 3 epitope KLIC has
the potential to elicit, in active vaccination, a
protective antibody (“CLONE 3”) that broadly
neutralizes ninety-eight percent of all known
HIV strains. This is more than any other
vaccine candidate whose study results have
been published.
The reason why Dr Fauci and the NIH were going after this antibody because they knew the power it had, and more than likely they were just going to shelve it to continue with their policy of selling drugs and not a cure. Under oath we know that Dr Fauci said it had "utility" & "commercial value" at that time. But lucky Dr Cotropia beat them to the punch and had already patented Clone 3 in 1989, hence why the judge ruled in their favor since it had already been patented 10 yrs prior.
Hey Valuator, no problem and here you go. From the Bioclonetics former funding page which is no longer active.......
As we have earlier reported, our parent monoclonal antibody has been previously tested in 5 international labs and shown to effectively neutralize multiple HIV isolates (strains of the virus) (http://www.bioclonetics.com/validation.html). From the parent antibody, we have prepared the required recombinant antibodies, required by the FDA for use in patient therapy, and initial tests have been conducted at the Institute of Tropical Medicine, University of Antwerp, Belgium.
From these tests results, the effectiveness of our recombinant antibody as compared to all other anti-HIV monoclonal antibodies thus far produced by pharma and the NIH, our recombinant tested at 2.6 times more effective than the best no. 1 antibody – VRC01 – and 6 times more effective than the no. 2 next best anti-HIV monoclonal antibody – VRC01 – (both produced by Vaccine Research Center, in conjunction with the NIH). We are conducting additional tests on our recombinant antibodies at The Scripps Institute in California and at Responsive BioServices in Georgia.
Rockie .do.,you..think that is..basicly..just a .. question infering it' could have an answer that is..at the surface taken as the obvious. . if and when , it's asked.. at any point of price lows..
That leads to another one so it would ..go without saying.
Which leads to aniother question much more below the surface does a CEO release his infm that could or in some cases should be on the.. basis of watching his own corp. stock price at certain levels.
Nope. There is a difference between a amateurishly run company and a scam. Sorry, the “scam” claims have never held any weight here. No intelligent investor has or will ever believe them either. And there are many indisputable reasons why.
There are numerous major partnerships ongoing with well known, legitimate, established companies. Those WOULD NEVER occur were this a “scam”.
There are multiple partnerships and collabs with well known Universities world wide. Those would not happen were this a “scam”
There are multiple advisors and board members, all well known with solid reps. Again, these would not happen were this a “scam”.
And maybe the biggest proof of all this isn’t a “scam”. There is no dilution.
End of story. Any company running a stock scam is actively diluting, bc otherwise there is literally no purpose to be scamming investors.
These guys have run this small bio company two years in without diluting. That fact alone is all anyone needs to know when questioning the “scam” claims.
They have a long way to go with improving investor confidence at this point and improving the way the company is run and finally getting things in order and milestones met. But this is no scam. 100% fact. Nothing else to say.
TK, I agree with your thoughts. Can you share where you got those stats on Clone 3? Thanks!
MAGA do you think Charles knows exactly how and why the stock is trading the way it has for last several months.
They..want.shares..watchin,.smart..money..swooping..down.to.. steal~ Along with them Now+thinking Billionaire Buffet smart money guy as he goes after shares to buy the company. . He says he..is buying the company with his shares and getting rich .. knowing what Is going on behind the scenes
He also says in online intvw how would I know what price is tomorrow I buy the corp in shares and then I had started getting rich
And went on to say
that was my error before I was in my 50's and why it happened in that period
Because
It was an.. Error ....not to think this way in earlier times
Which also means at these levels there is some thinking this
..
.. owning a part of the Co. in shares and waiting is not the worst at prices as this
Thank God .. thank heaven we are not...paying ..15 - .,30 so we can all get rich with any assets in
2b - I don't have any doubt that they are trying to squeeze/steal shares from scared retail.
It all started with the organized takedown during the emerging growth conference. That was the starting point. There were a bunch of FTD's and they desperately needed to cover. After that, the manipulation went into overdrive in early January 2022 with VIRT+OTCX, who successfully drove this under from .16 to under .10, then disappeared. A few days later we broke .10 again, and both VIRT+OTCX immediately popped back in completely synced up, drove us comfortably under .10, then disappeared for good. It was 100% organized/coordinated, and has not stopped except to reset the RSI every few months.
Let us hope for the best. The wait is only getting shorter.
No worries.
MP...If..were...pos'..to.say ..good,,news..new..opp'..for..ppl..to..get..wealth_ riding this breakthrough cure to aids.. as millions of lives get saved around the world after being infected..with buyers getting a new chance and possibly the last chance!!
Which it may just be that.. as a possible last chance vs all the put down taking up the perspective of the messages sounding as of it's a negative.. helping sidelines sit as the American eagle to swoop down and buy as low as imagination can take it and take shares from frightened holders.. As this being _ the [American way ]
Instead of talking as Warren Buffet who said he did not get his wealth Quoting avail online in so many words
He was saying he did not know the price the next day
He decided to buy stocks as a way to buy into companies knowing what they were doing ..
And that's when he stopped losing out and got wealthy after he reached the 50's and was buying stock from mid teens
And he pointed out how many years it took to realize the error of not doing it that in that way
But ., we read much less about it being said as muzzled said to infdr a put down.. ? And yet sidelinees holding there powder must love the put down
Thank God the guy knows when to release infm and he may be giving newbies a last chance
A last chance..
.. to again buy bottom prices it would be in the right perspective to the opportunity as it presents itself and why the shorts help traders who are smart money to follow the way down and come in with shorts where they buy in.
Instead it appears as the infm looking as a negative posting
Yet fortunes are made when prices are beaten down buy thus method of shorts and the smart money followed it
What happened 19 or 20 months ago that might be the reason for holding the price down for that amount of time.
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |